161 related articles for article (PubMed ID: 10780826)
1. Effects of GABA-transporter (GAT) inhibitors on rat behaviour in open-field and elevated plus-maze.
Schmitt U; Hiemke C
Behav Pharmacol; 1999 Mar; 10(2):131-7. PubMed ID: 10780826
[TBL] [Abstract][Full Text] [Related]
2. Behavioral effects of GABA(A) receptor stimulation and GABA-transporter inhibition.
Schmitt U; Lüddens H; Hiemke C
Pharmacol Biochem Behav; 2000 Feb; 65(2):351-6. PubMed ID: 10672990
[TBL] [Abstract][Full Text] [Related]
3. Tiagabine, a gamma-amino-butyric acid transporter inhibitor impairs spatial learning of rats in the Morris water-maze.
Schmitt U; Hiemke C
Behav Brain Res; 2002 Jul; 133(2):391-4. PubMed ID: 12110474
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic-like effects of acute and chronic GABA transporter inhibition in rats.
Schmitt U; Lüddens H; Hiemke C
J Neural Transm (Vienna); 2002 May; 109(5-6):871-80. PubMed ID: 12111474
[TBL] [Abstract][Full Text] [Related]
5. Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1.
Borden LA; Murali Dhar TG; Smith KE; Weinshank RL; Branchek TA; Gluchowski C
Eur J Pharmacol; 1994 Oct; 269(2):219-24. PubMed ID: 7851497
[TBL] [Abstract][Full Text] [Related]
6. Basic mechanisms of gabitril (tiagabine) and future potential developments.
Meldrum BS; Chapman AG
Epilepsia; 1999; 40 Suppl 9():S2-6. PubMed ID: 10612355
[TBL] [Abstract][Full Text] [Related]
7. Tiagabine, a specific gamma-aminobutyric acid transporter-1 inhibitor, in the treatment of psychosis.
Sharma RP; Martis B; Davis JM; Omens R; Janicak PG
J Clin Psychopharmacol; 2001 Jun; 21(3):347-9. PubMed ID: 11386503
[No Abstract] [Full Text] [Related]
8. Bi-directional transport of GABA in human embryonic kidney (HEK-293) cells stably expressing the rat GABA transporter GAT-1.
Sitte HH; Singer EA; Scholze P
Br J Pharmacol; 2002 Jan; 135(1):93-102. PubMed ID: 11786484
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of uptake, steady-state currents, and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugs.
Eckstein-Ludwig U; Fei J; Schwarz W
Br J Pharmacol; 1999 Sep; 128(1):92-102. PubMed ID: 10498839
[TBL] [Abstract][Full Text] [Related]
10. Age-dependence of the anticonvulsant effects of the GABA uptake inhibitor tiagabine in vitro.
Sabau A; Frahm C; Pfeiffer M; Breustedt J; Piechotta A; Numberger M; Engel D; Heinemann U; Draguhn A
Eur J Pharmacol; 1999 Nov; 383(3):259-66. PubMed ID: 10594317
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel GABA uptake inhibitors. 3. Diaryloxime and diarylvinyl ether derivatives of nipecotic acid and guvacine as anticonvulsant agents.
Knutsen LJ; Andersen KE; Lau J; Lundt BF; Henry RF; Morton HE; Naerum L; Petersen H; Stephensen H; Suzdak PD; Swedberg MD; Thomsen C; Sørensen PO
J Med Chem; 1999 Sep; 42(18):3447-62. PubMed ID: 10479278
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of background GABA uptake in rat hippocampal slices.
Frahm C; Engel D; Draguhn A
Neuroreport; 2001 Jun; 12(8):1593-6. PubMed ID: 11409722
[TBL] [Abstract][Full Text] [Related]
13. The GABA transporter and its inhibitors.
Soudijn W; van Wijngaarden I
Curr Med Chem; 2000 Oct; 7(10):1063-79. PubMed ID: 10911018
[TBL] [Abstract][Full Text] [Related]
14. Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia.
Costa C; Leone G; Saulle E; Pisani F; Bernardi G; Calabresi P
Stroke; 2004 Feb; 35(2):596-600. PubMed ID: 14726544
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus effects of tiagabine and related GABAergic drugs in rats.
McDonald LM; Sheppard WF; Staveley SM; Sohal B; Tattersall FD; Hutson PH
Psychopharmacology (Berl); 2008 May; 197(4):591-600. PubMed ID: 18264695
[TBL] [Abstract][Full Text] [Related]
16. Anticonvulsant properties of two GABA uptake inhibitors NNC 05-2045 and NNC 05-2090, not acting preferentially on GAT-1.
Dalby NO; Thomsen C; Fink-Jensen A; Lundbeck J; Søkilde B; Man CM; Sørensen PO; Meldrum B
Epilepsy Res; 1997 Jul; 28(1):51-61. PubMed ID: 9255599
[TBL] [Abstract][Full Text] [Related]
17. Protection of malonate-induced GABA but not dopamine loss by GABA transporter blockade in rat striatum.
Zeevalk GD; Manzino L; Sonsalla PK
Exp Neurol; 2002 Jul; 176(1):193-202. PubMed ID: 12093096
[TBL] [Abstract][Full Text] [Related]
18. Effects of valproate, vigabatrin and tiagabine on GABA uptake into human astrocytes cultured from foetal and adult brain tissue.
Fraser CM; Sills GJ; Butler E; Thompson GG; Lindsay K; Duncan R; Howatson A; Brodie MJ
Epileptic Disord; 1999 Sep; 1(3):153-7. PubMed ID: 10937147
[TBL] [Abstract][Full Text] [Related]
19. In vivo labeling of the central GABA uptake carrier with 3H-Tiagabine.
Suzdak PD; Swedberg MD; Andersen KE; Knutsen LJ; Braestrup C
Life Sci; 1992; 51(24):1857-68. PubMed ID: 1333027
[TBL] [Abstract][Full Text] [Related]
20. Correlation between anticonvulsant activity and inhibitory action on glial gamma-aminobutyric acid uptake of the highly selective mouse gamma-aminobutyric acid transporter 1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and its N-alkylated analogs.
White HS; Sarup A; Bolvig T; Kristensen AS; Petersen G; Nelson N; Pickering DS; Larsson OM; Frølund B; Krogsgaard-Larsen P; Schousboe A
J Pharmacol Exp Ther; 2002 Aug; 302(2):636-44. PubMed ID: 12130726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
